Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement

Core Viewpoint - Predictmedix AI Inc. has successfully closed the final tranche of its non-brokered private placement, raising a total of $612,650 across all tranches, indicating strong investor interest and strategic alignment with long-term goals [2][3][5]. Group 1: Financial Details - In the final tranche, the company issued 3,050,000 units at a price of $0.05 per unit, resulting in gross proceeds of $152,500 [3][4]. - The total capital raised from all tranches of the offering amounts to $612,650 [3]. Group 2: Warrant Information - Each unit consists of one common share and one half of a common share purchase warrant, with each warrant allowing the purchase of one half common share at a price of C$0.15 for 36 months [4]. - If the volume weighted average price of the common shares reaches or exceeds $0.30 for 10 consecutive trading days, the company may accelerate the expiry date of the warrants [4]. Group 3: Strategic Approach - The company emphasized a disciplined, value-focused approach to the financing, prioritizing strategic contributions from investors over merely maximizing capital [5]. - The completion of this financing is expected to provide clarity and momentum for advancing initiatives in key markets [5]. Group 4: Company Overview - Predictmedix AI Inc. is an emerging provider of rapid health screening and remote patient care solutions, utilizing AI technology to analyze physiological data and predict health issues [6]. - The company's Smarthealth AI stations can assess 19 physiological vital parameters and detect impairments due to drugs, alcohol, fatigue, or mental illnesses [6].